Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bennu Pharmaceuticals is a specialty pharmaceutical company based in Pennington, New Jersey, operating as a subsidiary of Zydus Lifesciences (formerly Cadila Healthcare). The company is primarily focused on the development and commercialization of high-quality generic and specialty pharmaceutical products for the United States market. Its portfolio includes a range of topical and systemic treatments across therapeutic areas such as dermatology, anti-infectives, and antiviral therapy. Bennu leverages the extensive global manufacturing and research infrastructure of its parent company, Zydus, to provide affordable medicine to patients. Key products in its commercial lineup include generic versions of acyclovir, clobetasol propionate, and mupirocin. The company serves as a strategic arm for Zydus's expansion into the American specialty pharma sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bennu Pharmaceuticals.